The overlooked threat of land take from wind energy infrastructures: Quantification, drivers and policy gaps.

Wind harnessing is a fast-developing and cost-effective Renewable Energy Source, but the land impacts of wind power stations are often overlooked or underestimated. We digitized land take, i.e., the generation of artificial land, derived from 90 wind power stations in Greece constructed between 2002 and 2020 (1.2 GW). We found substantial land take impacts of 7729 m2/MW (3.5 m2/MWh) of new artificial land, 148 m/MW of new roads and 174 m/MW of widened roads on average. Models showed that the number and size of wind turbines, the absence of other existing infrastructures and the elevational difference across new access roads increased artificial land generation. The elevational difference across new and widened access roads also increased their length. New wind power stations in Greece are planned to be installed at higher elevations and in terrains facing higher risks for soil erosion and soil biodiversity. The general tendency in the European Union is to sit fewer wind power stations in mountainous and forested land. Still, this pattern is inversed in several countries, particularly in Southern Europe. After screening 29 policy and legal documents, we found that land take is indirectly inferred in the global policy but more directly in the European policy through five non-legally binding documents and three Directives. However, the current European energy policies seem to conflict with nature conservation policies, risking land take acceleration. The study provides insights for reducing land take when planning and constructing wind power stations. We underline the need for better quantification of land take and its integration in the complex process of sustainable spatial planning of investments.

C-reactive protein response is higher in early than in late ovarian hyperstimulation syndrome.

OBJECTIVES: Many in vitro fertilization (IVF) complications are inflammatory by nature, some of which are even life-threatening. We evaluated the response of C-reactive protein (CRP) in IVF complications, especially in early and late ovarian hyperstimulation syndrome (OHSS), to support clinical decision making in gynecological emergency policlinics. STUDY DESIGN: In a prospective two-year study at Helsinki University Hospital, Finland, we recruited patients with IVF complications including moderate or severe OHSS (n=47 patients: 36 early and 14 late OHSS cases), or other IVF complications (n=13). As controls, we recruited women in an uncomplicated IVF cycle (n=27). Serial blood samples (CRP, blood count, platelets, albumin, estradiol, creatinine, and electrolytes) were collected from patients upon admission to the emergency polyclinic and during and after treatment on the ward, and from the controls prior, during, and after the IVF protocol. All samples were categorized according to oocyte pick-up (OPU). The statistics included comparisons between and within the study groups, and receiver-operating characteristic (ROC) curve analysis for diagnostic accuracy of CRP for early OHSS at emergency polyclinics. RESULTS: On admission, CRP did not differentiate OHSS from other IVF complications, but CRP was higher in early (median 21; IQR 8-33mg/L) than in late (6; 3-9mg/L, p=0.001) OHSS. In ROC analysis for CRP (12mg/L), the area under the curve (AUC) was 0.74 (p=0.001) with sensitivity of 69% and specificity of 71% for early OHSS. CRP was significantly higher (28; 10-46mg/L) in patients with early OHSS two days after oocyte pick-up (OPU) than in the controls (5; <3-9mg/L, p<0.001). The level normalized by 12 days, similarly to the controls. On the ward, the peak CRP was higher if early OHSS was complicated with infection (108; 49-166mg/L) than without infection (20; 8-32mg/L, p=0.001). Late OHSS was associated with hypoalbuminemia (19.6; 16.2-23.1g/L, p<0.001) and thrombocytosis (494; 427-561 E9/L, p=0.004; comparisons to early OHSS). CONCLUSIONS: Early OHSS associates with a distinct rise in CRP level beyond that induced by uncomplicated oocyte pick-up, whereas the CRP levels in late OHSS are comparable to those in the control cycles. CRP identifies, but cannot distinguish IVF complications.